Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Hurricane Ida Added to Automatic Extreme and Uncontrollable Circumstances Policy for MIPS

Oncology Practice Insider

In response to the Federal Emergency Management Agency (FEMA) designation of Hurricane Ida as a major disaster, the Centers for Medicare and Medicaid Services (CMS) has determined that the automatic extreme and uncontrollable circumstances (EUC) policy will apply to Merit-based Incentive Payment System (MIPS) eligible clinicians in FEMA-designated disaster areas of Louisiana, Mississippi, New York, New Jersey, and Missouri.

MIPS eligible clinicians in these areas will be automatically identified and receive a neutral payment adjustment for the 2023 MIPS payment year. During the data submission period for the 2021 performance period (January 3, 2022 to March 31, 2022), all 4 performance categories for these clinicians will be weighted at 0%, resulting in a score equal to the performance threshold.

  • However, if MIPS eligible clinicians in these areas choose to submit data on 2 or more performance categories, they’ll be scored on those categories and receive a 2023 MIPS payment adjustment based on their 2021 MIPS final score.

The automatic EUC policy won’t apply to MIPS eligible clinicians participating in MIPS as a group, virtual group, or Alternative Payment Model (APM) Entity.

For more information, please reference the Extreme and Uncontrollable Circumstances Overview section on the MIPS > About Exception Applications page and review the fact sheet.

Contact the Quality Payment Program at 1-866-288-8292 or by e-mail, Monday-Friday 8 AM - 8 PM ET. To receive assistance more quickly, please consider calling during non-peak hours—before 10 AM and after 2 PM ET. Customers who are hearing impaired can dial 711 to be connected to a TRS Communications Assistant.